Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.9251 -0.0849 (-8.41%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Ensysce Biosciences Regains Compliance with Nasdaq
Via ACCESSWIRE
News headline image
Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website
Via ACCESSWIRE
News headline image
Ensysce Biosciences to Participate in Upcoming Industry Events
Via ACCESSWIRE
News headline image
Ensysce Biosciences Reports First Quarter 2023 Financial Results
Via ACCESSWIRE
News headline image
Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering
Via ACCESSWIRE
News headline image
Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today? ↗
With Ensysce Biosciences achieving testing success regarding its overdose protection drug, ENSC stock soared on the implications. 
Via InvestorPlace
News headline image
Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
Via ACCESSWIRE
News headline image
Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development
Via ACCESSWIRE
News headline image
Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website
Via ACCESSWIRE
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 63 companies hit new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Ensysce Biosciences's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Ensysce Biosciences Announces Positive Results from Oral Human Abuse Potential Trial for PF614
Via ACCESSWIRE
News headline image
Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
Via ACCESSWIRE
News headline image
Ensysce Biosciences Announces Completion of Enrollment for Groundbreaking Opioid Overdose Protection Study
Via ACCESSWIRE
News headline image
Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study
Ensysce Biosciences, Inc. (NASDAQ: ENSC) operates as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology to 
Via Spotlight Growth
News headline image
Why Are Ensysce Biosciences Shares Are Trading Higher Today ↗
Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the company's first pain medication with overdose protection,  
Via Benzinga
News headline image
Dr. Lynn Kirkpatrick, Featured Speaker to Discuss Ensysce Overdose Protection Platform at DCAT Seminar
Via ACCESSWIRE
News headline image
Ensysce Biosciences Announces Critical Step in Human Abuse Potential Study of PF614 With Database Lock
Via ACCESSWIRE
News headline image
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
News headline image
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
News headline image
Ensysce Biosciences And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
The Dow Jones rose around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
News headline image
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
News headline image
ObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying ↗
The Dow Jones jumped by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  During Tuesday, 79 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.